Published in J Acquir Immune Defic Syndr on July 01, 2017
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health (2003) 3.22
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS (2005) 2.91
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr (2004) 2.90
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev (2003) 2.03
Evaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. Ann Epidemiol (2010) 1.97
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health (2013) 1.65
Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. Addiction (2013) 1.64
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction (2012) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.50
Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. Int J STD AIDS (2002) 1.50
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health (2009) 1.49
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend (2012) 1.41
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction (2007) 1.41
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend (2008) 1.41
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
The HCV Synthesis Project: scope, methodology, and preliminary results. BMC Med Res Methodol (2008) 1.34
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health (2011) 1.32
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.31
Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women. Am J Public Health (2010) 1.31
Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy (2009) 1.23
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend (2010) 1.21
Reconsidering the internet as an HIV/STD risk for men who have sex with men. AIDS Behav (2010) 1.21
Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.21
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens (2008) 1.20
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS One (2012) 1.19
Missed opportunities for HIV testing among high-risk heterosexuals. Sex Transm Dis (2009) 1.19
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res (2007) 1.18
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend (2005) 1.17
Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin Infect Dis (2011) 1.16
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med (2008) 1.13
Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. Int J Drug Policy (2007) 1.13
A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health (2008) 1.13
Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend (2009) 1.12
Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. J Infect Dis (2006) 1.11
Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol (2010) 1.10
Herpes simplex virus-2 and HIV among noninjecting drug users in New York city. Sex Transm Dis (2007) 1.09
Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care. Open AIDS J (2012) 1.08
Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ (2006) 1.08
Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users. Drug Alcohol Depend (2009) 1.07
Recruitment-adjusted estimates of HIV prevalence and risk among men who have sex with men: effects of weighting venue-based sampling data. Public Health Rep (2011) 1.07
Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health (2007) 1.06
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend (2007) 1.05
Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS (2010) 1.05
Impact of the September 11th attacks in New York City on drug users: a preliminary assessment. J Urban Health (2002) 1.05
Spatial distribution of HIV/AIDS in Yunnan province, People's Republic of China. Geospat Health (2011) 1.05
Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units. AIDS Patient Care STDS (2005) 1.03
Patterns of exchange sex and HIV infection in high-risk heterosexual men and women. J Urban Health (2011) 1.03
Estimated HIV incidence among high-risk heterosexuals in New York City, 2007. J Acquir Immune Defic Syndr (2011) 1.02
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health (2004) 1.01
Sexual and injection-related risks in Puerto Rican-born injection drug users living in New York City: A mixed-methods analysis. Harm Reduct J (2011) 1.00
HIV incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China. Sex Transm Dis (2012) 0.99
Short-term Mobility and Increased Partnership Concurrency among Men in Zimbabwe. PLoS One (2013) 0.97
Agent, host, and environment: hepatitis C virus in people who inject drugs. J Infect Dis (2011) 0.97
A reexamination of connectivity trends via exponential random graph modeling in two IDU risk networks. Subst Use Misuse (2013) 0.97
HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection. PLoS One (2013) 0.95
Spatial recruitment bias in respondent-driven sampling: Implications for HIV prevalence estimation in urban heterosexuals. AIDS Behav (2014) 0.95
Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health (2006) 0.94
Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China. BMC Infect Dis (2014) 0.94
Estimating HIV incidence and the correlates of recent infection in venue-sampled men who have sex with men in New York City. AIDS Behav (2012) 0.93
A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City. Subst Use Misuse (2014) 0.92
A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug Alcohol Depend (2004) 0.91
The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. AIDS Educ Prev (2014) 0.91
High HIV prevalence among low-income, Black women in New York City with self-reported HIV negative and unknown status. J Womens Health (Larchmt) (2013) 0.90